Aurinia Pharmaceuticals Inc

(AUPH) Trade

By |

Profile

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The firm is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.

Contact Information

Website: www.auriniapharma.com
Email: ir@auriniapharma.com
Main Phone: +1 250 744-2487
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: NSD
CEO: Richard M. Glickman
Employees: 33
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 5.81 $ 0.09 (1.57%)
Last Price 5.81 Change $ 0.09 Change % 1.57 Tick N/A
Bid 5.70 Bid Size 500.00 Ask 5.90 Ask Size 100.00
Open 5.76 High 5.82 Low 5.70 Prev Close 5.72
Last Trade Volume 277,937 52 Wk Hi 7.60 52 Wk Low 4.41
Market Cap 490.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,478,054.00 EPS (TTM) N/A PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 12 12 12 12
Standard Deviation 2.61 2.61 2.61 2.61
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41